(Q28207513)

https://api.crossref.org/works/10.1038/SJ.ONC.1206813

18 March 2024

4

0 references

Maria Rita Nicotra

3

0 references

author name string

Ester Fonsatti

1

0 references

Maresa Altomonte

2

0 references

Michele Maio

full work available at URL

5

0 references

language of work or name

English

0 references

publication date

29 September 2003

0 references

https://www.nature.com/articles/1206813.pdf

file format

Portable Document Format

online access status

open access

1 reference

Europe PubMed Central

PubMed publication ID

14528280

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528280

https://www.nature.com/articles/1206813.pdf

18 March 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206813

https://www.nature.com/articles/1206813

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206813

18 March 2024

0 references

22

0 references

issue

42

0 references

page(s)

6557-63

0 references

cites work

Expression of endoglin mRNA and protein in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

A murine model of hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Endoglin modulates cellular responses to TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

CD105 (endoglin) expression on hematopoietic stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Regulation of transforming growth factor-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Differential levels of soluble endoglin (CD105) in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Lack of specificity of endoglin expression for tumor blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Strategies for vascular targeting in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Assignment of the human endoglin gene (END) to 9q34-->qter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Cell type specificity of the human endoglin promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin expression in early development is associated with vasculogenesis and angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

A simple analysis of gene expression and variability in gene arrays based on repeated observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Role of angiogenesis in patients with cerebral ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Defective angiogenesis in mice lacking endoglin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line Bonna-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Mechanisms and future directions for angiogenesis-based cancer therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Expression of endoglin (CD105) in tumor blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206813

7 January 2021

Hypoxia-induced angiogenesis during carcinogenesis

20

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206813